Hoboken, NJ, United States of America

Shawn A Springfield

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn A Springfield. Retrieved from https://idiyas.com/inventor/shawn-a-springfield-9wab5mjz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Shawn A Springfield

Introduction

Shawn A Springfield is a notable inventor based in Hoboken, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for phosphodiesterase-4. His work is characterized by a commitment to advancing medical science through innovative methods.

Latest Patents

Shawn A Springfield holds a patent for a "Method of preparing inhibitors phosphodiesterase-4." This invention outlines a one-pot method for preparing intermediates that are essential in creating effective inhibitors of phosphodiesterase-4. The patent also details a method for preparing phosphodiesterase inhibitors, which are crucial for various therapeutic applications.

Career Highlights

Shawn is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the field. His dedication to research and development has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Shawn has worked alongside notable colleagues such as Jennifer Albaneze-Walker and Jerry Anthony Murry. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Shawn A Springfield's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to influence the development of new therapies and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…